Contact

Category: Dogs

Dogs analyzes the canine-specific clinical pharmacology, heartworm chemoprophylaxis, dermatological protocols, and pharmacogenetic breed safety profiles for domestic dogs (Canis lupus familiaris).

Foundational Pillars
Pharmacological Framework
Clinical Directory
Frequently Asked Questions

Foundational Clinical Pillars

Core Reference

The Longevity of Ivermectin: A Detailed Chronicle of Clinical Use Across Five Decades

Essential pharmacogenetic screening guide for herding breeds susceptible to ABCB1 (MDR1) mutations.

Clinical Benchmark

How Long Has Ivermectin Been Around? A 50-Year History from 1974 to the Present

Comprehensive taxonomy of susceptible canine nematodes, filariae, and external parasites.

Safety Standard

Where Did Ivermectin Come From? The Discovery of Streptomyces avermitilis and Satoshi Ōmura

Evaluates external flea eradication claims, limitations, and modern isoxazoline comparisons.

Canine Posology, ABCB1 Gene Mutations & Heartworm Prophylaxis

Canine therapeutics represent the most prevalent veterinary application of ivermectin. The drug functions primarily as a microfilaricide and chemoprophylactic agent against Dirofilaria immitis. When dosed at the approved prophylactic level of 6 mcg/kg monthly, ivermectin demonstrates an exceptionally high therapeutic index with virtually complete safety across all canine breeds.

However, when treating active demodectic or sarcoptic mange, dosages must increase by fifty to one hundred times (300 to 600 mcg/kg). At these elevated concentrations, dogs carrying the ABCB1-1Δ (MDR1) genetic mutation experience catastrophic P-glycoprotein deficiency at the blood-brain barrier. Without functional P-glycoprotein efflux pumps, ivermectin crosses freely into the central nervous system, accumulating in brain tissue and triggering life-threatening GABA-ergic neurotoxicity.

Clinical CategoryTarget Posology RangeABCB1 Genetic Safety Profile
Heartworm Chemoprophylaxis6 – 12 mcg/kg (Monthly)100% Safe across all breeds, including homozygous mutant collies
Intestinal Nematode Control50 – 100 mcg/kg (Single dose)Generally well tolerated; caution in known homozygous mutants
Demodectic Acariasis Therapy300 – 600 mcg/kg (Daily)STRICTLY CONTRAINDICATED in ABCB1 mutant/carrier breeds
Sarcoptic Mange Eradication200 – 400 mcg/kg (Bi-weekly)Contraindicated in sensitive breeds; use selamectin or isoxazolines

Breeds predisposed to this genetic mutation include Collies (up to 70% allele frequency), Australian Shepherds, Shetland Sheepdogs, Old English Sheepdogs, and sight hounds. Veterinary best practices mandate DNA cheek-swab testing (via Washington State University or certified genetic labs) to determine ABCB1 status prior to prescribing high-dose avermectin therapy.

Topic Directory & Methodologies

Canine Breed Sensitivity & Genetic Screening

Therapeutic Protocols & Preventive Standards

Advanced Formulations & Protocols

Frequently Asked Clinical Questions

Is ivermectin heartworm medicine safe for collies?

Yes. At the standard preventive dose of 6 mcg/kg (found in commercial heartworm chewables), ivermectin is completely safe even for collies homozygous for the ABCB1 (MDR1) mutation.

What causes ivermectin sensitivity in certain dog breeds?

A 4-base-pair deletion mutation in the ABCB1 (MDR1) gene produces a non-functional P-glycoprotein pump, allowing the drug to accumulate unchecked within the brain tissues.

Does ivermectin kill fleas on dogs?

No. Standard ivermectin dosages do not provide reliable flea mortality. Modern veterinary medicine utilizes isoxazolines (fluralaner, afoxolaner) or spinosad for effective flea eradication.

Notice & Clinical Safe Harbor: This educational reference is maintained by the Veterinary Parasitology & Pharmacology Standards Desk for academic, informational, and clinical research purposes. Data models published veterinary pharmacology literature, statutory veterinary monographs, and established anthelmintic posology standards. This portal does not provide certified individual veterinary medical diagnosis, prescription services, or personalized treatment regimens. For clinical diagnoses, suspected parasitic toxicosis, and individualized dosing protocols, always consult an actively licensed veterinary practitioner in your jurisdiction.

AI Editorial Policy